The effects of moderate whole grain consumption on fasting glucose and lipids, gastrointestinal symptoms, and microbiota

Nutrients

Volumn 9, Issue 2, 2017, Pages

  Cooper, Danielle N ^a   Kable, Mary E ^b   Marco, Maria L ^a   De Leon, Angela ^a   Rust, Bret ^a,b   Baker, Julita E ^a   Horn, William ^b   Burnett, Dustin ^b   Keim, Nancy L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Bowel movement frequency; Brown rice; Fasting blood lipids; Fasting glucose; Gastrointestinal symptoms; Maize; Microbiota; Whole grains; Whole wheat

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; RNA 16S; TRIACYLGLYCEROL; CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ABDOMINAL PAIN; ACTINOBACTERIA; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; FLATULENCE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HUMAN; LIKERT SCALE; MALE; MICROBIAL COMMUNITY; MICROFLORA; NAUSEA; PLETHYSMOGRAPHY; POLYMERASE CHAIN REACTION; RNA SEQUENCE; TELEPHONE INTERVIEW; WHOLE GRAIN; ADVERSE EFFECTS; BACTERIUM; BLOOD; DEFECATION; DIARRHEA; DIET; DIET RESTRICTION; FEEDING BEHAVIOR; FOOD HANDLING; GASTROINTESTINAL DISEASES; GLUCOSE BLOOD LEVEL; GROWTH, DEVELOPMENT AND AGING; INTESTINE FLORA; MAIZE; METABOLISM; ORYZA; RANDOMIZED CONTROLLED TRIAL; WHEAT; YOUNG ADULT;

ADULT; BACTERIA; BLOOD GLUCOSE; BODY COMPOSITION; CHOLESTEROL; DEFECATION; DIARRHEA; DIET; FASTING; FEEDING BEHAVIOR; FEMALE; FOOD HANDLING; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HUMANS; LIPIDS; MALE; ORYZA; TRIGLYCERIDES; TRITICUM; WHOLE GRAINS; YOUNG ADULT; ZEA MAYS;

EID: 85013792273     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9020173     Document Type: Article

References (97)

1. Food Availability (Per Capita) Data System. Available online: http://ers.usda.gov/data-products/food-availability-per-capita-data-system.aspx (accessed on 20 April 2016).
2. Albertson, A.M.; Good, C.K.; Eldridge, A.L.; Holschuh, N.M. Whole grain consumption and food sources in the united states: Data from nhanes 1999–2000 and the usda’s pyramid servings database for the usda survey food codes. FASEB J. 2005, 19, A87–A87.
3. McGill, C.; Fulgoni, V.L., III; Devareddy, L. Ten-year trends in fiber and whole grain intakes and food sources for the united states population: National health and nutrition examination survey 2001–2010. Nutrients 2015, 7, 1119–1130. [CrossRef] [PubMed]
4. Okarter, N.; Liu, R.H. Health benefits of whole grain phytochemicals. Crit. Rev. Food Sci. Nutr. 2010, 50, 193–208. [CrossRef] [PubMed]
5. Van der Kamp, J.W.; Poutanen, K.; Seal, C.J.; Richardson, D.P. The healthgrain definition of ’whole grain’. Food Nutr. Res. 2014, 58, 22100. [CrossRef] [PubMed]
6. International, AACC. Whole grain definition. Cereal Foods World 1999, 45, 79.
7. Bett-Garber, K.L.; Lea, J.M.; Champagne, E.T.; McClung, A.M. Whole-grain rice flavor associated with assorted bran colors. J. Sens. Stud. 2012, 27, 78–86. [CrossRef]
8. Slavin, J. Whole grains and digestive health. Cereal Chem. 2010, 87, 292–296. [CrossRef]
9. Slavin, J.L. Whole grains, refined grains and fortified refined grains: What’s the difference? Asia Pac. J. Clin. Nutr. 2000, 9, S23–S27. [CrossRef] [PubMed]
10. Marquart, L.; Chan, H.W.; Orsted, M.; Schmitz, K.A.; Arndt, E.A.; Jacobs, D.R. Gradual incorporation of whole-grain flour into grain-based products. Cereal Foods World 2006, 51, 114–117. [CrossRef]
11. Montonen, J.; Knekt, P.; Jarvinen, R.; Aromaa, A.; Reunanen, A. Whole-grain and fiber intake and the incidence of type 2 diabetes. Am. J. Clin. Nutr. 2003, 77, 622–629. [PubMed]
12. Borneo, R.; Leon, A.E. Whole grain cereals: Functional components and health benefits. Food Funct. 2012, 3, 110–119. [CrossRef] [PubMed]
13. Ampatzoglou, A.; Atwal, K.K.; Maidens, C.M.; Williams, C.L.; Ross, A.B.; Thielecke, F.; Jonnalagadda, S.S.; Kennedy, O.B.; Yaqoob, P. Increased whole grain consumption does not affect blood biochemistry, body composition, or gut microbiology in healthy, low-habitual whole grain consumers. J. Nutr. 2015, 145, 215–221. [CrossRef] [PubMed]
14. Cooper, D.N.; Martin, R.J.; Keim, N.L. Does whole grain consumption alter gut microbiota and satiety? Healthcare 2015, 3, 364–392. [CrossRef] [PubMed]
15. Jackson, K.H.; West, S.G.; Vanden Heuvel, J.P.; Jonnalagadda, S.S.; Ross, A.B.; Hill, A.M.; Grieger, J.A.; Lemieux, S.K.; Kris-Etherton, P.M. Effects of whole and refined grains in a weight-loss diet on markers of metabolic syndrome in individuals with increased waist circumference: A randomized controlled-feeding trial. Am. J. Clin. Nutr. 2014, 100, 577–586. [CrossRef] [PubMed]
16. Modi, P. Benefits of low glycemic and high satiety index foods for obesity and diabetes control and management. In Nutrients, Dietary Supplements, and Nutriceuticals; Cost Analysis Versus Clinical Benefits; Springer: New York, NY, USA, 2011; pp. 403–424.
17. Zhou, A.L.; Hergert, N.; Rompato, G.; Lefevre, M. Whole grain oats improve insulin sensitivity and plasma cholesterol profile and modify gut microbiota composition in C57BL/6J mice. J. Nutr. 2015, 145, 222–230. [CrossRef] [PubMed]
18. Rebello, C.J.; Greenway, F.L.; Finley, J.W. Whole grains and pulses: A comparison of the nutritional and health benefits. J. Agric. Food Chem. 2014, 62, 7029–7049. [CrossRef] [PubMed]
19. Costabile, A.; Klinder, A.; Fava, F.; Napolitano, A.; Foglian, V.; Leonard, C.; Gibson, G.R.; Tuohy, K.M. Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: A double-blind, placebo-controlled, crossover study. Br. J. Nutr. 2008, 99, 110–120. [CrossRef] [PubMed]
20. Raninen, K.; Lappi, J.; Mykkanen, H.; Poutanen, K. Dietary fiber type reflects physiological functionality: Comparison of grain fiber, inulin, and polydextrose. Nutr. Rev. 2011, 69, 9–21. [CrossRef] [PubMed]
21. Nyman, M.; Siljestrom, M.; Pedersen, B.; Knudsen, K.E.B.; Asp, N.G.; Johansson, C.G.; Eggum, B.O. Dietary fiber content and composition in 6 cereals at different extraction rates. Cereal Chem. 1984, 61, 14–19.
22. Frankenfield, D.C.; Muth, E.R.; Rowe, W.A. The harris-benedict studies of human basal metabolism: History and limitations. J. Am. Diet. Assoc. 1998, 98, 439–445. [CrossRef]
23. Lewis, S.J.; Heaton, K.W. Stool form scale as a useful guide to intestinal transit time. Scand. J. Gastroenterol. 1997, 32, 920–924. [CrossRef] [PubMed]
24. Ferguson, L.W. A study of the likert technique of attitude scale construction. J. Soc. Psychol. 1941, 13, 51–57. [CrossRef]
25. Hsieh, Y.-H.; Peterson, C.M.; Raggio, A.; Keenan, M.J.; Martin, R.J.; Ravussin, E.; Marco, M.L. Impact of different fecal processing methods on assessments of bacterial diversity in the human intestine. Front. Microbiol. 2016, 7, 1–11. [CrossRef] [PubMed]
26. Salonen, A.; Nikkila, J.; Jalanka-Tuovinen, J.; Immonen, O.; Rajilic-Stojanovic, M.; Kekkonen, R.A.; Palva, A.; de Vos, W.M. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: Effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J. Microbiol. Methods 2010, 81, 127–134. [CrossRef] [PubMed]
27. Wang, Q.; Garrity, G.M.; Tiedje, J.M.; Cole, J.R. Naive bayesian classifier for rapid assignment of rrna sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73, 5261–5267. [CrossRef] [PubMed]
28. Caporaso, J.G.; Lauber, C.L.; Walters, W.A.; Berg-Lyons, D.; Lozupone, C.A.; Turnbaugh, P.J.; Fierer, N.; Knight, R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 2011, 108, 4516–4522. [CrossRef] [PubMed]
29. Hamady, M.; Walker, J.J.; Harris, J.K.; Gold, N.J.; Knight, R. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat. Methods 2008, 5, 235–237. [CrossRef] [PubMed]
30. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Pena, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. Qiime allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335–336. [CrossRef] [PubMed]
31. Aronesty, E. Ea-utils: Command-Line Tools for Processing Biological Sequencing Data. Available online: https://github.com/ExpressionAnalysis/ea-utils (accessed on 17 April 2011).
32. Edgar, R.C.; Haas, B.J.; Clemente, J.C.; Quince, C.; Knight, R. Uchime improves sensitivity and speed of chimera detection. Bioinformatics 2011, 27, 2194–2200. [CrossRef] [PubMed]
33. Edgar, R.C. Search and clustering orders of magnitude faster than blast. Bioinformatics 2010, 26, 2460–2461. [CrossRef] [PubMed]
34. Bokulich, N.A.; Subramanian, S.; Faith, J.J.; Gevers, D.; Gordon, J.I.; Knight, R.; Mills, D.A.; Caporaso, J.G. Quality-filtering vastly improves diversity estimates from illumina amplicon sequencing. Nat. Methods 2013, 10, 57–59. [CrossRef] [PubMed]
35. Wu, G.D.; Lewis, J.D.; Hoffmann, C.; Chen, Y.Y.; Knight, R.; Bittinger, K.; Hwang, J.; Chen, J.; Berkowsky, R.; Nessel, L.; et al. Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16s sequence tags. BMC Microbiol. 2010, 10, 206. [CrossRef] [PubMed]
36. Segata, N.; Izard, J.; Waldron, L.; Gevers, D.; Miropolsky, L.; Garrett, W.S.; Huttenhower, C. Metagenomic biomarker discovery and explanation. Genome Biol. 2011, 12, R60. [CrossRef] [PubMed]
37. Kwong, K.S.; Holland, B.; Cheung, S.H. A modified benjamini-hochberg multiple comparisons procedure for controlling the false discovery rate. J. Stat. Plan. Inference 2002, 104, 351–362. [CrossRef]
38. De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from europe and rural africa. Proc. Natl. Acad. Sci. USA 2010, 107, 14691–14696. [CrossRef] [PubMed]
39. Mariat, D.; Firmesse, O.; Levenez, F.; Guimaraes, V.D.; Sokol, H.; Dore, J.; Corthier, G.; Furet, J.P. The firmicutes/bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009, 9, 123. [CrossRef] [PubMed]
40. Lange, E. Oats products as functional food. Zywnosc-Nauka Technol. Jakosc 2010, 17, 7–24. [CrossRef]
41. Fardet, A. New hypotheses for the health-protective mechanisms of whole-grain cereals: What is beyond fibre? Nutr. Res. Rev. 2010, 23, 65–134. [CrossRef] [PubMed]
42. Bressani, R.; Breuner, M.; Ortiz, M.A. Acid-detergent and neutro-detergent fiber and mineral elements content of maize and tortilla. Arch. Latinoam. Nutr. 1989, 39, 382–391. [PubMed]
43. Sumczynski, D.; Bubelova, Z.; Fisera, M. Determination of chemical, insoluble dietary fibre, neutral-detergent fibre and in vitro digestibility in rice types commercialized in Czech markets. J. Food Compos. Anal. 2015, 40, 8–13. [CrossRef]
44. Lai, V.M.F.; Lu, S.; He, W.H.; Chen, H.H. Non-starch polysaccharide compositions of rice grains with respect to rice variety and degree of milling. Food Chem. 2007, 101, 1205–1210. [CrossRef]
45. Rose, D.J.; Patterson, J.A.; Hamaker, B.R. Structural differences among alkali-soluble arabinoxylans from maize (Zea mays), rice (oryza sativa), and wheat (triticum aestivum) brans influence human fecal fermentation profiles. J. Agric. Food Chem. 2010, 58, 493–499. [CrossRef] [PubMed]
46. Mohan, V.; Spiegelman, D.; Sudha, V.; Gayathri, R.; Hong, B.; Praseena, K.; Anjana, R.M.; Wedick, N.M.; Arumugam, K.; Malik, V.; et al. Effect of brown rice, white rice, and brown rice with legumes on blood glucose and insulin responses in overweight Asian Indians: A randomized controlled trial. Diabetes Technol. Ther. 2014, 16, 317–325. [CrossRef] [PubMed]
47. Tosh, S.M. Review of human studies investigating the post-prandial blood-glucose lowering ability of oat and barley food products. Eur. J. Clin. Nutr. 2013, 67, 310–317. [CrossRef] [PubMed]
48. Ranawana, V.; Clegg, M.E.; Shafat, A.; Henry, C.J. Postmastication digestion factors influence glycemic variability in humans. Nutr. Res. 2011, 31, 452–459. [CrossRef] [PubMed]
49. Bornhorst, G.M.; Stroebinger, N.; Rutherfurd, S.M.; Singh, R.P.; Moughan, P.J. Properties of gastric chyme from pigs fed cooked brown or white rice. Food Biophys. 2013, 8, 12–23. [CrossRef]
50. Oishi, K.; Yamamoto, S.; Itoh, N.; Nakao, R.; Yasumoto, Y.; Tanaka, K.; Kikuchi, Y.; Fukudome, S.; Okita, K.; Takano-Ishikawa, Y. Wheat alkylresorcinols suppress high-fat, high-sucrose diet-induced obesity and glucose intolerance by increasing insulin sensitivity and cholesterol excretion in male mice. J. Nutr. 2015, 145, 199–206. [CrossRef] [PubMed]
51. Arora, T.; Sharma, R.; Frost, G. Propionate. Anti-obesity and satiety enhancing factor? Appetite 2011, 56, 511–515. [CrossRef] [PubMed]
52. Everard, A.; Cani, P.D. Gut microbiota and GLP-1. Rev. Endocr. Metab. Disord. 2014, 15, 189–196. [CrossRef] [PubMed]
53. Chambers, E.S.; Viardot, A.; Psichas, A.; Morrison, D.J.; Murphy, K.G.; Sagen, E.K.; Varghese, Z.; MacDougall, K.; Preston, T. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adult. BMJ 2014, 1–11. [CrossRef] [PubMed]
54. Todesco, T.; Rao, A.V.; Bosello, O.; Jenkins, D.J.A. Propionate lowers blood-glucose and alters lipid-metabolism in healthy-subjects. Am. J. Clin. Nutr. 1991, 54, 860–865. [PubMed]
55. Frost, G.; Sleeth, M.L.; Sahuri-Arisoylu, M.; Lizarbe, B.; Cerdan, S.; Brody, L.; Anastasovska, J.; Ghourab, S.; Hankir, M.; Zhang, S.; et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 2014, 5, 3611. [CrossRef] [PubMed]
56. Venter, C.S.; Vorster, H.H.; Cummings, J.H. Effects of dietary propionate on carbohydrate and lipid-metabolism in healthy-volunteers. Am. J. Gastroenterol. 1990, 85, 549–553. [PubMed]
57. Johansson, E.V.; Nilsson, A.C.; Ostman, E.M.; Bjorck, I.M.E. Effects of indigestible carbohydrates in barley on glucose metabolism, appetite and voluntary food intake over 16 h in healthy adults. Nutr. J. 2013, 12, 46. [CrossRef] [PubMed]
58. McIntosh, G.H.; Noakes, M.; Royle, P.J.; Foster, P.R. Whole-grain rye and wheat foods and markers of bowel health in overweight middle-aged men. Am. J. Clin. Nutr. 2003, 77, 967–974. [PubMed]
59. Youn, M.; Csallany, A.S.; Gallaher, D.D. Whole grain consumption has a modest effect on the development of diabetes in the goto-kakisaki rat. Br. J. Nutr. 2012, 107, 192–201. [CrossRef] [PubMed]
60. Kristensen, M.; Jensen, M.G.; Riboldi, G.; Petronio, M.; Bugel, S.; Toubro, S.; Tetens, I.; Astrup, A. Wholegrain vs. Refined wheat bread and pasta. Effect on postprandial glycemia, appetite, and subsequent ad libitum energy intake in young healthy adults. Appetite 2010, 54, 163–169. [CrossRef] [PubMed]
61. Cano, J.M.M.; Aguilar, A.C.; Hernandez, J.C. Lipid-lowering effect of maize-based traditional mexican food on a metabolic syndrome model in rats. Lipids Health Dis. 2013, 12, 35. [CrossRef] [PubMed]
62. Mackie, A.; Bajka, B.; Rigby, N. Roles for dietary fibre in the upper gi tract: The importance of viscosity. Food Res. Int. 2016, 88, 234–238. [CrossRef]
63. Knudsen, K.E.B.; Laerke, H.N. Whole grain cereals and gut health. Agro Food Ind. Hi-Tech 2008, 19, 6–8.
64. Odes, H.S.; Lazovski, H.; Stern, I.; Madar, Z. Double-blind trial of a high dietary fiber, mixed grain cereal in patients with chronic constipation and hyperlipidemia. Nutr. Res. 1993, 13, 979–985. [CrossRef]
65. Bird, A.R.; Vuaran, M.S.; King, R.A.; Noakes, M.; Keogh, J.; Morell, M.K.; Topping, D.L. Wholegrain foods made from a novel high-amylose barley variety (himalaya 292) improve indices of bowel health in human subjects. Br. J. Nutr. 2008, 99, 1032–1040. [CrossRef] [PubMed]
66. Kim, J.Y.; Son, B.K.; Lee, S.S. Effects of adlay, buckwheat, and barley on transit time and the antioxidative system in obesity induced rats. Nutr. Res. Pract. 2012, 6, 208–212. [CrossRef] [PubMed]
67. De Vries, J.; Miller, P.E.; Verbeke, K. Effects of cereal fiber on bowel function: A systematic review of intervention trials. World J. Gastroenterol. 2015, 21, 8952–8963. [CrossRef] [PubMed]
68. De Vries, J.; Birkett, A.; Hulshof, T.; Verbeke, K.; Gibes, K. Effects of cereal, fruit and vegetable fibers on human fecal weight and transit time: A comprehensive review of intervention trials. Nutrients 2016, 8, 130. [CrossRef] [PubMed]
69. Slavin, J. Health aspects of dietary fibre. Fibre-Rich Wholegrain Foods Improv. Qual. 2013, 237, 61–75.
70. Belobrajdic, D.P.; Bird, A.R. The potential role of phytochemicals in wholegrain cereals for the prevention of type-2 diabetes. Nutr. J. 2013, 12, 62. [CrossRef] [PubMed]
71. Coughlin, S.S. Toward a road map for global -omics: A primer on -omic technologies. Am. J. Epidemiol. 2014, 180, 1188–1195. [CrossRef] [PubMed]
72. Scott, K.P.; Martin, J.C.; Duncan, S.H.; Flint, H.J. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. Fems Microbiol. Ecol. 2014, 87, 30–40. [CrossRef] [PubMed]
73. Mirande, C.; Kadlecikova, E.; Matulova, M.; Capek, P.; Bernalier-Donadille, A.; Forano, E.; Bera-Maillet, C. Dietary fibre degradation and fermentation by two xylanolytic bacteria bacteroides xylanisolvens xb1at and roseburia intestinalis xb6b4 from the human intestine. J. Appl. Microbiol. 2010, 109, 451–460. [PubMed]
74. Hamer, H.M.; De Preter, V.; Windey, K.; Verbeke, K. Functional analysis of colonic bacterial metabolism: Relevant to health? Am. J. Physiol.-Gastrointest. Liver Physiol. 2012, 302, G1–G9. [CrossRef] [PubMed]
75. Lozupone, C.A.; Stombaugh, J.I.; Gordon, J.I.; Jansson, J.K.; Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489, 220–230. [CrossRef] [PubMed]
76. Bosscher, D.; Breynaert, A.; Pieters, L.; Hermans, N. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. J. Physiol. Pharmacol. 2009, 60, 5–11. [PubMed]
77. Cani, P.D.; Neyrinck, A.M.; Fava, F.; Knauf, C.; Burcelin, R.G.; Tuohy, K.M.; Gibson, G.R.; Delzenne, N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50, 2374–2383. [CrossRef] [PubMed]
78. Christensen, E.G.; Licht, T.R.; Kristensen, M.; Bahl, M.I. Bifidogenic effect of whole-grain wheat during a 12-week energy-restricted dietary intervention in postmenopausal women. Eur. J. Clin. Nutr. 2013, 67, 1316–1321. [CrossRef] [PubMed]
79. Koren, O.; Goodrich, J.K.; Cullender, T.C.; Spor, A.; Laitinen, K.; Backhed, H.K.; Gonzalez, A.; Werner, J.J.; Angenent, L.T.; Knight, R.; et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012, 150, 470–480. [CrossRef] [PubMed]
80. Gibson, G.R.; Probert, H.M.; Van Loo, J.; Rastall, R.A.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17, 259–275. [CrossRef] [PubMed]
81. Mobley, A.R.; Jones, J.M.; Rodriguez, J.; Slavin, J.; Zelman, K.M. Identifying practical solutions to meet america’s fiber needs: Proceedings from the food & fiber summit. Nutrients 2014, 6, 2540–2551. [PubMed]
82. Zhong, Y.; Nyman, M.; Fak, F. Modulation of gut microbiota in rats fed high-fat diets by processing whole-grain barley to barley malt. Mol. Nutr. Food Res. 2015, 59, 2066–2076. [CrossRef] [PubMed]
83. De Angelis, M.; Montemurno, E.; Vannini, L.; Cosola, C.; Cavallo, N.; Gozzi, G.; Maranzano, V.; Di Cagno, R.; Gobbetti, M.; Gesualdo, L. Effect of whole-grain barley on the human fecal microbiota and metabolome. Appl. Environ. Microbiol. 2015, 81, 7945–7956. [CrossRef] [PubMed]
84. Everard, A.; Belzer, C.; Geurts, L.; Ouwerkerk, J.P.; Druart, C.; Bindels, L.B.; Guiot, Y.; Derrien, M.; Muccioli, G.G.; Delzenne, N.M.; et al. Cross-talk between akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 2013, 110, 9066–9071. [CrossRef] [PubMed]
85. Joyce, S.A.; Gahan, C.G.M. The gut microbiota and the metabolic health of the host. Curr. Opin. Gastroenterol. 2014, 30, 120–127. [CrossRef] [PubMed]
86. Greer, R.L.; Dong, X.X.; Moraes, A.C.F.; Zielke, R.A.; Fernandes, G.R.; Peremyslova, E.; Vasquez-Perez, S.; Schoenborn, A.A.; Gomes, E.P.; Pereira, A.C.; et al. Akkermansia muciniphila mediates negative effects of ifn gamma on glucose metabolism. Nat. Commun. 2016, 7, 13329. [CrossRef] [PubMed]
87. Remely, M.; Tesar, I.; Hippe, B.; Gnauer, S.; Rust, P.; Haslberger, A.G. Gut microbiota composition correlates with changes in body fat content due to weight loss. Benef. Microbes 2015, 6, 431–439. [CrossRef] [PubMed]
88. Sarao, L.K.; Arora, M. Probiotics, prebiotics, and microencapsulation: A review. Crit. Rev. Food Sci. Nutr. 2017, 57, 344–371. [CrossRef] [PubMed]
89. Hang, I.; Rinttila, T.; Zentek, J.; Kettunen, A.; Alaja, S.; Apajalahti, J.; Harmoinen, J.; de Vos, W.M.; Spillmann, T. Effect of high contents of dietary animal-derived protein or carbohydrates on canine faecal microbiota. BMC Vet. Res. 2012, 8, 90. [CrossRef] [PubMed]
90. Magnusson, K.R.; Hauck, L.; Jeffrey, B.M.; Elias, V.; Humphrey, A.; Nath, R.; Perrone, A.; Bermudez, L.E. Relationships between diet-related changes in the gut microbiome and cognitive flexibility. Neuroscience 2015, 300, 128–140. [CrossRef] [PubMed]
91. Schwab, C.; Berry, D.; Rauch, I.; Rennisch, I.; Ramesmayer, J.; Hainzl, E.; Heider, S.; Decker, T.; Kenner, L.; Muller, M.; et al. Longitudinal study of murine microbiota activity and interactions with the host during acute inflammation and recovery. ISME J. 2014, 8, 1101–1114. [CrossRef] [PubMed]
92. Gevers, D.; Kugathasan, S.; Denson, L.A.; Vazquez-Baeza, Y.; Van Treuren, W.; Ren, B.Y.; Schwager, E.; Knights, D.; Song, S.J.; Yassour, M.; et al. The treatment-naive microbiome in new-onset crohn’s disease. Cell Host Microbe 2014, 15, 382–392. [CrossRef] [PubMed]
93. Haro, C.; Garcia-Carpintero, S.; Alcala-Diaz, J.F.; Gomez-Delgado, F.; Delgado-Lista, J.; Perez-Martinez, P.; Zuniga, O.A.R.; Quintana-Navarro, G.M.; Landa, B.B.; Clemente, J.C.; et al. The gut microbial community in metabolic syndrome patients is modified by diet. J. Nutr. Biochem. 2016, 27, 27–31. [CrossRef] [PubMed]
94. Chen, W.G.; Liu, F.L.; Ling, Z.X.; Tong, X.J.; Xiang, C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 2012, 7, e39743. [CrossRef] [PubMed]
95. Vaziri, N.D.; Wong, J.; Pahl, M.; Piceno, Y.M.; Yuan, J.; DeSantis, T.Z.; Ni, Z.M.; Nguyen, T.H.; Andersen, G.L. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013, 83, 308–315. [CrossRef] [PubMed]
96. Kelly, T.N.; Bazzano, L.A.; Ajami, N.J.; He, H.; Zhao, J.Y.; Petrosino, J.F.; Correa, A.; He, J. Gut microbiome associates with lifetime cardiovascular disease risk profile among bogalusa heart study participants. Circ. Res. 2016, 119, 956–964. [CrossRef] [PubMed]
97. Kaakoush, N.O. Insights into the role of erysipelotrichaceae in the human host. Front. Cell. Infect. Microbiol. 2015, 5, 84. [CrossRef] [PubMed]